Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3

Injectable Poly-DL-lactic Acid | DL10014A | CAS No- 26023-30-3 is an acid terminated Pharma / Medical Grade homopolymer of DL-lactide with an inherent viscosity midpoint of 1.4 dl/g. It is supplied in the form of white micronized powder.

Product Description

CAS Number26023-30-3
Systematic NamePoly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Injectable Poly-Dl-lactic Acid, Ultra-Pure PDLLA.
EPA Registry NamePolylactic acid
Substance TypePLA | DL10014A | Inherent Viscosity : 1.3 - 1.7 dL/g | Acid terminated |DL- Lactide 100% | Mw 130-220 kDa Biodegradable Polymer, Excipient, Non-Active pharmaceutical ingredient, Nanoparticles.
SynonymPLA, Poly(DL-lactide) acid terminated, PDLLA
ApplicationsDrug delivery formulations, ACL Scrow, bioresorbable implants.

GET QUOTE

Specification

Appearance White powder.
Solubility Soluble in methylene chloride. Insoluble in water.
FT NMR (PROTON) Should comply
Viscosity (0.5% in CHCl3 at 30°C) Between 1.30-1.70 dL/g
Residual monomer L-Lactide ≤ 0.5 %
Residual solvent acetone ≤ 0.1 %
Residual solvent toluene ≤ 890 PPM
Total Residual solvent ≤ 1000 PPM
Acid number 8 - 15 mg KOH/g
Heavy metal ≤ 10 PPM
Tin ≤ 200 PPM
Sulphated Ash ≤ 0.1 %
TAMC ≤ 2000 CFU/g
TYMC ≤ 200 CFU/g
Bacterial Endotoxins ≤ 2000 EU/g
Self life 2 Years
See also:DL-PLA